These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
396 related items for PubMed ID: 15368443
41. The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice. Cong WN, Tao RY, Tian JY, Liu GT, Ye F. Life Sci; 2008 May 07; 82(19-20):983-90. PubMed ID: 18417155 [Abstract] [Full Text] [Related]
42. [Mechanism of hepatocyte regeneration inhibition in rats with liver fibrosis induced by lipogenic methionine-choline- deficient diet]. Mu YP, Xi XH, Chen XR. Zhonghua Yi Xue Za Zhi; 2009 Dec 29; 89(48):3430-6. PubMed ID: 20223120 [Abstract] [Full Text] [Related]
43. Bile acids override steatosis in farnesoid X receptor deficient mice in a model of non-alcoholic steatohepatitis. Wu W, Liu X, Peng X, Xue R, Ji L, Shen X, Chen S, Gu J, Zhang S. Biochem Biophys Res Commun; 2014 May 23; 448(1):50-5. PubMed ID: 24747563 [Abstract] [Full Text] [Related]
45. Comparison of murine steatohepatitis models identifies a dietary intervention with robust fibrosis, ductular reaction, and rapid progression to cirrhosis and cancer. Wei G, An P, Vaid KA, Nasser I, Huang P, Tan L, Zhao S, Schuppan D, Popov YV. Am J Physiol Gastrointest Liver Physiol; 2020 Jan 01; 318(1):G174-G188. PubMed ID: 31630534 [Abstract] [Full Text] [Related]
46. A methionine-choline-deficient diet elicits NASH in the immunodeficient mouse featuring a model for hepatic cell transplantation. Pelz S, Stock P, Brückner S, Christ B. Exp Cell Res; 2012 Feb 01; 318(3):276-87. PubMed ID: 22108588 [Abstract] [Full Text] [Related]
47. Effect of Trifolium pratense extract on methionine-choline-deficient diet-induced steatohepatitis in C57BL/6 mice. Chen T, Zhong FJ, Hong YM, Su WJ, Zhuang LL, Qiu LX. Chin J Nat Med; 2014 Mar 01; 12(3):194-8. PubMed ID: 24702805 [Abstract] [Full Text] [Related]
48. Antioxidants vitamin E and 1-aminobenzotriazole prevent experimental non-alcoholic steatohepatitis in mice. Nan YM, Wu WJ, Fu N, Liang BL, Wang RQ, Li LX, Zhao SX, Zhao JM, Yu J. Scand J Gastroenterol; 2009 Mar 01; 44(9):1121-31. PubMed ID: 19606393 [Abstract] [Full Text] [Related]
49. Telmisartan attenuates progression of steatohepatitis in mice: role of hepatic macrophage infiltration and effects on adipose tissue. Kudo H, Yata Y, Takahara T, Kawai K, Nakayama Y, Kanayama M, Oya T, Morita S, Sasahara M, Mann DA, Sugiyama T. Liver Int; 2009 Aug 01; 29(7):988-96. PubMed ID: 19386026 [Abstract] [Full Text] [Related]
50. Polyunsaturated fat in the methionine-choline-deficient diet influences hepatic inflammation but not hepatocellular injury. Lee GS, Yan JS, Ng RK, Kakar S, Maher JJ. J Lipid Res; 2007 Aug 01; 48(8):1885-96. PubMed ID: 17526933 [Abstract] [Full Text] [Related]
51. Diabetes is a progression factor for hepatic fibrosis in a high fat fed mouse obesity model of non-alcoholic steatohepatitis. Lo L, McLennan SV, Williams PF, Bonner J, Chowdhury S, McCaughan GW, Gorrell MD, Yue DK, Twigg SM. J Hepatol; 2011 Aug 01; 55(2):435-44. PubMed ID: 21184785 [Abstract] [Full Text] [Related]
52. Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice. Tomita K, Oike Y, Teratani T, Taguchi T, Noguchi M, Suzuki T, Mizutani A, Yokoyama H, Irie R, Sumimoto H, Takayanagi A, Miyashita K, Akao M, Tabata M, Tamiya G, Ohkura T, Hibi T. Hepatology; 2008 Aug 01; 48(2):458-73. PubMed ID: 18666257 [Abstract] [Full Text] [Related]
53. The pro-inflammatory action of tumour necrosis factor-α in non-alcoholic steatohepatitis is independent of the NSMAF gene product. Mas E, Danjoux M, Garcia V, Carpentier S, Ségui B, Levade T. Dig Liver Dis; 2013 Feb 01; 45(2):147-54. PubMed ID: 23044079 [Abstract] [Full Text] [Related]
54. Glycine alleviates liver injury induced by deficiency in methionine and or choline in rats. Barakat HA, Hamza AH. Eur Rev Med Pharmacol Sci; 2012 Jun 01; 16(6):728-36. PubMed ID: 22913202 [Abstract] [Full Text] [Related]
55. Rodent nutritional model of non-alcoholic steatohepatitis: species, strain and sex difference studies. Kirsch R, Clarkson V, Shephard EG, Marais DA, Jaffer MA, Woodburne VE, Kirsch RE, Hall Pde L. J Gastroenterol Hepatol; 2003 Nov 01; 18(11):1272-82. PubMed ID: 14535984 [Abstract] [Full Text] [Related]
56. Attenuation of steatohepatitis, fibrosis, and carcinogenesis in mice fed a methionine-choline deficient diet by CCAAT/enhancer-binding protein homologous protein deficiency. Toriguchi K, Hatano E, Tanabe K, Takemoto K, Nakamura K, Koyama Y, Seo S, Taura K, Uemoto S. J Gastroenterol Hepatol; 2014 May 01; 29(5):1109-18. PubMed ID: 24329600 [Abstract] [Full Text] [Related]
57. Differential hepatotoxicity of dietary and DNL-derived palmitate in the methionine-choline-deficient model of steatohepatitis. Pierce AA, Pickens MK, Siao K, Grenert JP, Maher JJ. BMC Gastroenterol; 2015 Jun 24; 15():72. PubMed ID: 26103964 [Abstract] [Full Text] [Related]
58. Early hepatic microvascular injury in response to acetaminophen toxicity. Ito Y, Bethea NW, Abril ER, McCuskey RS. Microcirculation; 2003 Oct 24; 10(5):391-400. PubMed ID: 14557822 [Abstract] [Full Text] [Related]
59. Thioredoxin-binding protein-2 deficiency enhances methionine-choline deficient diet-induced hepatic steatosis but inhibits steatohepatitis in mice. Ahsan MK, Okuyama H, Hoshino Y, Oka S, Masutani H, Yodoi J, Nakamura H. Antioxid Redox Signal; 2009 Oct 24; 11(10):2573-84. PubMed ID: 19764881 [Abstract] [Full Text] [Related]
60. [Peroxisome proliferator activated receptor gamma activation and overexpression prevent hepatocellular apoptosis of nutritional fibrotic steatohepatitis in mice]. Nan YM, Han F, Kong LB, Li Y, Wang RQ, Zhao SX. Zhonghua Gan Zang Bing Za Zhi; 2011 Jul 24; 19(7):521-6. PubMed ID: 22152244 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]